Arizona State Retirement System Buys 267,742 Shares of Rocket Lab Corporation $RKLB

Key Points

• Arizona State Retirement System increased its Rocket Lab stake by 205% in the second quarter, purchasing 267,742 shares and bringing its holdings to 398,369 shares valued at approximately $40.5 million. Institutional investors collectively own 71.78% of the company.
• Rocket Lab insiders have been selling shares, including CFO Adam Spice’s $8.8 million sale, while insiders sold $312.9 million worth of stock over the past three months. The company also faces execution concerns, including a possible delay of Neutron’s first launch to 2027.
• Despite those risks, analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and an average price target of $108.83. Rocket Lab’s new IMM Apex solar cell could strengthen its space-systems business, although near-term revenue and customer impacts remain unquantified.

Arizona State Retirement System grew its stake in Rocket Lab Corporation (NASDAQ:RKLB - Free Report) by 205.0% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 398,369 shares of the rocket manufacturer's stock after purchasing an additional 267,742 shares during the period. Arizona State Retirement System owned about 0.07% of Rocket Lab worth $40,494,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in RKLB. AQR Capital Management LLC grew its position in Rocket Lab by 114.0% during the first quarter. AQR Capital Management LLC now owns 174,308 shares of the rocket manufacturer's stock worth $3,117,000 after buying an additional 92,849 shares in the last quarter. NewEdge Advisors LLC raised its holdings in Rocket Lab by 1,812.1% in the 1st quarter. NewEdge Advisors LLC now owns 36,807 shares of the rocket manufacturer's stock valued at $658,000 after acquiring an additional 34,882 shares in the last quarter. Jones Financial Companies Lllp lifted its position in shares of Rocket Lab by 53.8% in the 1st quarter. Jones Financial Companies Lllp now owns 15,745 shares of the rocket manufacturer's stock worth $282,000 after acquiring an additional 5,507 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Rocket Lab by 13.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 773,548 shares of the rocket manufacturer's stock worth $13,831,000 after acquiring an additional 90,758 shares during the period. Finally, Focus Partners Wealth grew its holdings in shares of Rocket Lab by 1.0% during the 1st quarter. Focus Partners Wealth now owns 67,584 shares of the rocket manufacturer's stock worth $1,206,000 after purchasing an additional 681 shares in the last quarter. Institutional investors own 71.78% of the company's stock.

Insider Buying and Selling

In other news, CFO Adam Spice sold 140,157 shares of the company's stock in a transaction dated Wednesday, September 2nd. The shares were sold at an average price of $62.63, for a total value of $8,778,032.91. Following the sale, the chief financial officer owned 1,155,967 shares of the company's stock, valued at approximately $72,398,213.21. This represents a 10.81% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Marvin Clevenger sold 15,051 shares of the stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $69.63, for a total transaction of $1,048,001.13. Following the sale, the insider owned 458,924 shares of the company's stock, valued at $31,954,878.12. This trade represents a 3.18% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 3,624,371 shares of company stock worth $312,944,881 in the last three months. Company insiders own 8.40% of the company's stock.

Rocket Lab News Roundup

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Rocket Lab announced the production release of its IMM Apex solar cell, which delivers 31.5% beginning-of-life efficiency while reducing cell mass by 40%. The germanium-free design could lower costs, ease supply-chain constraints, and be installed as a drop-in replacement in existing systems. Rocket Lab says its solar technology already powers more than 1,100 satellites. Rocket Lab Introduces High-Efficiency Solar Cell
• Positive Sentiment: The launch of IMM Apex strengthens Rocket Lab’s space-systems business and could support growth as satellite demand increases. The company says optimized manufacturing can produce the cells in multi-100-kilowatt volumes. Rocket Lab Announces Production Release of Germanium-Free IMM Apex Solar Cells
• Positive Sentiment: Analyst optimism remains a key support. Recent coverage included a bullish rating and an $83 target from Berenberg, while previously published targets ranged from $96 to $135, with a reported median of $120. Other coverage highlighted Rocket Lab’s backlog, expanding defense communications opportunities, and long-term satellite growth. Why Wall Street Is Betting on Rocket Lab
• Positive Sentiment: Reports that ARK Invest added to its Rocket Lab position, along with a broader rally in space-related stocks following SpaceX’s public-market debut, provided additional momentum and visibility for RKLB. Cathie Wood Is Moving Money From Palantir Into Rocket Lab
• Neutral Sentiment: The IMM Apex announcement is strategically important, but the release did not identify specific new customer contracts or quantify its near-term revenue contribution. Adoption and production execution remain key factors for converting the technology into financial results.
• Negative Sentiment: Neutron’s first launch may slip into 2027, and a recent rocket test failure has heightened concerns about execution and the timing of Rocket Lab’s larger launch opportunity. The proposed Iridium acquisition is another major milestone investors are watching. Rocket Lab’s Neutron Just Slipped Again
• Negative Sentiment: Insider-trading data showed 97 open-market sales and no purchases over the past six months, including substantial selling by CEO Peter Beck and other executives. That activity may reinforce concerns about valuation and management confidence.

Rocket Lab Price Performance

Shares of RKLB traded up $1.61 during mid-day trading on Tuesday, reaching $65.87. The company had a trading volume of 24,090,146 shares, compared to its average volume of 23,263,232. Rocket Lab Corporation has a twelve month low of $37.57 and a twelve month high of $151.00. The company has a debt-to-equity ratio of 0.01, a current ratio of 5.48 and a quick ratio of 4.98. The company's 50-day moving average is $74.56 and its 200-day moving average is $84.82. The company has a market capitalization of $39.41 billion, a P/E ratio of -243.95 and a beta of 2.60.

Rocket Lab (NASDAQ:RKLB - Get Free Report) last announced its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The company had revenue of $234.07 million during the quarter, compared to analyst estimates of $231.62 million. On average, equities analysts anticipate that Rocket Lab Corporation will post -0.2 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently commented on RKLB shares. Wall Street Zen lowered Rocket Lab from a "hold" rating to a "sell" rating in a research note on Saturday, August 15th. Stifel Nicolaus set a $132.00 price target on shares of Rocket Lab in a research note on Thursday, June 4th. Morgan Stanley reissued an "overweight" rating on shares of Rocket Lab in a report on Wednesday, July 8th. Citizens Jmp restated a "market outperform" rating and issued a $130.00 price objective on shares of Rocket Lab in a research note on Tuesday, August 11th. Finally, KeyCorp reaffirmed an "overweight" rating on shares of Rocket Lab in a report on Tuesday, August 11th. Four investment analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $108.83.

About Rocket Lab

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company's primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company's propulsion capabilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.